1. 1-24 of 205 1 2 3 4 5 6 7 8 9 »
    1. Kevin Mansell Elected to Fossil Group, Inc. Board of Directors

      Kevin Mansell Elected to Fossil Group, Inc. Board of Directors

      RICHARDSON, Texas, May 22, 2019 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (Nasdaq GS: FOSL) (the “Company”) announced the election of Kevin Mansell to its Board of Directors, effective May 22, 2019.  With Mr. Mansell’s election, the Company’s Board of Directors consists of nine members, including eight independent directors and one current member of senior management...

      Read Full Article
    2. Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

      Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

      Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, effective immediately...

      Read Full Article
    3. Pacific Mercantile Bancorp Announces Election of Shannon F. Eusey and Michele S. Miyakawa to Board of Directors

      Pacific Mercantile Bancorp Announces Election of Shannon F. Eusey and Michele S. Miyakawa to Board of Directors

      COSTA MESA, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Pacific Mercantile Bancorp (Nasdaq: PMBC, the “Company”), the holding company of Pacific Mercantile Bank (the “Bank”), a wholly owned banking subsidiary, today announced the election of Shannon F. Eusey and Michele S. Miyakawa to the board of directors of Pacific Mercantile Bancorp at the Company’s annual of meeting of shareholders on May 15, 2019.  Ms. Eusey and Ms. Miyakawa are new additions to the Company’s board of directors and will also serve on the board of directors of Pacific Mercantile Bank...

      Read Full Article
    4. NewBridge Global Ventures Appoints Eric Baum to Board of Directors

      NewBridge Global Ventures Appoints Eric Baum to Board of Directors

      ALAMEDA, CA, May 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NewBridge Global Ventures, Inc. (“NewBridge” or the “Company”), (OTCQB: NBGV), a vertically integrated processing company focused on the legal and regulated cannabis and hemp industries, today announced the appointment of Eric Baum to its Board of Directors. The appointment is effective immediately and increases the Company’s Board to six directors, three of which are independent...

      Read Full Article
    5. MeiraGTx Appoints Nicole Seligman to Board of Directors

      MeiraGTx Appoints Nicole Seligman to Board of Directors

      LONDON and NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Nicole Seligman to its Board of Directors. Ms. Seligman is an accomplished leader with extensive executive, legal, compliance and governance experience...

      Read Full Article
    6. Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

      Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

      SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) --  Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced the completion of its merger with Alliqua BioMedical, Inc...

      Read Full Article
    7. Adverum Biotechnologies Announces Board Changes

      Adverum Biotechnologies Announces Board Changes

      MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Rekha Hemrajani, M.B.A., James Scopa, J.D., M.B.A., and Mark Lupher, Ph.D. to its Board of Directors, effective immediately...

      Read Full Article
    8. Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors

      Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors

      NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Dr. Thomas G. Moore has been appointed to its Board of Directors...

      Read Full Article
    9. Former Citi Card CEO Jud Linville Joins Board of Directors for Amino Payments

      Former Citi Card CEO Jud Linville Joins Board of Directors for Amino Payments

      PHILADELPHIA, April 23, 2019 (GLOBE NEWSWIRE) -- Amino® Payments, the leading transparency and payments company for digital advertising, announced today that Jud Linville, most recently the CEO of Global Cards and Consumer Services at Citi since 2010, with 20 years of executive experience at American Express, has joined Amino’s Board of Directors...

      Read Full Article
    10. Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors

      Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors

      COLUMBUS, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical company focused on the development and commercialization of female-specific oncology products, today announced the addition of Richard U. DeSchutter, Michael A. Friedman, M.D., and Stephen Rubino, Ph.D., to its board of directors...

      Read Full Article
    11. CohBar Announces the Appointment of David Greenwood to its Board of Directors

      CohBar Announces the Appointment of David Greenwood to its Board of Directors

      MENLO PARK, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced the appointment of David Greenwood to its Board of Directors...

      Read Full Article
    12. Identiv Nominates Retired U.S. Navy Vice Admiral Robin R. Braun for Election to Board of Directors

      Identiv Nominates Retired U.S. Navy Vice Admiral Robin R. Braun for Election to Board of Directors

      FREMONT, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Identiv, Inc. (NASDAQ: INVE), a global provider of physical security and secure identification, has announced that the Board of Directors has nominated Robin R. Braun to be elected as a director at the company's annual meeting of stockholders on May 29, 2019...

      Read Full Article
    13. ShotSpotter Appoints Merline Saintil to Board of Directors

      ShotSpotter Appoints Merline Saintil to Board of Directors

      NEWARK, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- ShotSpotter, Inc. (Nasdaq: SSTI), the leader in gunshot detection solutions that help law enforcement officials identify, locate and deter gun violence, today announced the addition of Merline Saintil to the company’s board of directors.  Saintil has held technology and operations leadership positions in many prominent Silicon Valley companies such as Intuit, Yahoo and Adobe. Saintil joins the board of ShotSpotter as the company approaches its second-year anniversary as a public company...

      Read Full Article
    14. Delta Apparel Appoints New Member to Board of Directors

      Delta Apparel Appoints New Member to Board of Directors

      GREENVILLE, S.C., April 11, 2019 (GLOBE NEWSWIRE) -- Delta Apparel, Inc. (NYSE American: DLA), a leading provider of core activewear and lifestyle apparel products, today announced the appointment of Glenda E. Hood to its Board of Directors. Ms. Hood brings to the Delta Apparel Board of Directors over 40 years of business, organizational and political leadership experience spanning multiple industries and sectors.  Ms. Hood concluded her political career in 2005 as the Secretary of State for the State of Florida after serving three terms as Mayor and Chief Executive Officer for the City of Orlando, Florida...

      Read Full Article
    15. InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors

      InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors

      SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced the appointment of Daniel G. Welch as executive chairman of the company’s board of directors, effective March 7, 2019.  Mr. Welch possesses more than 30 years of experience in both multinational pharmaceutical and biotechnology companies...

      Read Full Article
    16. Breaking News: GameStop Announces Agreement with Hestia Capital and Permit Enterprise Capital Partners

      Breaking News: GameStop Announces Agreement with Hestia Capital and Permit Enterprise Capital Partners

      GRAPEVINE, Texas, April 01, 2019 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) today announced that it has reached a cooperation agreement with Hestia Capital Partners LP (“Hestia”) and Permit Capital Enterprise Fund LP (“Permit”) under which two new independent directors will be added to the GameStop Board of Directors. Pursuant to the cooperation agreement, the Company will appoint an independent director from among the candidates nominated by Hestia and Permit...

      Read Full Article
    17. Fate Therapeutics Announces the Appointment of Karin Jooss, Ph.D. to its Board of Directors

      Fate Therapeutics Announces the Appointment of Karin Jooss, Ph.D. to its Board of Directors

      SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that Karin Jooss, Ph.D. has been appointed to the Company’s Board of Directors...

      Read Full Article
    1-24 of 205 1 2 3 4 5 6 7 8 9 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content